Morse Asset Management, Inc Eli Lilly & CO Transaction History

Morse Asset Management, Inc

$443 Million
Q3 2024

A detailed history of Morse Asset Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Morse Asset Management, Inc holds 11,019 shares of LLY stock, worth $8.46 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

11,019

Previous 11,047 0.25%

Holding current value

$8.46 Million

Previous $9.79 Million 0.26%

% of portfolio

2.21%

Previous 2.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	SELL	$772.14 - $960.02 $21,619 - $26,880	-28 Reduced 0.25%	11,019 $9.76 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $105,783 - $131,522	137 Added 1.26%	11,047 $9.79 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $165,995 - $208,170	-229 Reduced 2.06%	10,910 $9.88 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $415,132 - $555,388	701 Added 6.72%	11,139 $8.67 Million
Q4 2023 Feb 15, 2024	SELL	$525.19 - $619.13 $313,013 - $369,001	-596 Reduced 5.4%	10,438 $6.09 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $146,928 - $202,563	-338 Reduced 2.97%	11,034 $5.93 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $531,371 - $710,504	1,515 Added 15.37%	11,372 $5.33 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $97,537 - $114,553	314 Added 3.29%	9,857 $3.39 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $675,255 - $786,807	2,100 Added 28.21%	9,543 $3.49 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3.85 Million - $4.39 Million	-12,980 Reduced 63.56%	7,443 $2.41 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $830,057 - $974,610	2,978 Added 17.07%	20,423 $6.62 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $538,613 - $669,359	2,295 Added 15.15%	17,445 $5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.51 Million - $3.11 Million	11,150 Added 278.75%	15,150 $4.19 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $221,600 - $272,710	1,000 Added 33.33%	4,000 $924,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $541,650 - $700,620	3,000 New	3,000 $689,000
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $195,544 - $228,249	-1,765 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $196,462 - $231,250	1,765 New	1,765 $229,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.

Account

Morse Asset Management, Inc Eli Lilly & CO Transaction History